サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1308915

関節痛用注射剤市場：注射剤タイプ別、関節タイプ別、流通チャネル別-2023-2030年の世界予測

Joint Pain Injections Market by Injection Type, Joint Type, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 183 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
関節痛用注射剤市場：注射剤タイプ別、関節タイプ別、流通チャネル別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

関節痛用注射剤の世界市場は、2023年に45億5,540万米ドル、CAGR 10.92%で大きく成長し、2030年には94億2,397万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の関節痛用注射剤市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.関節痛用注射剤の世界市場規模および予測は？

2.予測期間中、世界の関節痛用注射剤市場を形成するCOVID-19の阻害要因と影響は？

3.関節痛用注射剤の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.関節痛用注射剤の世界市場における競争戦略は？

5.関節痛用注射剤の世界市場における技術動向と規制の枠組みは？

6.関節痛用注射剤の世界市場における主要ベンダーの市場シェアは？

7.関節痛用注射剤の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で関節疾患の有病率が増加
      • 関節リウマチ、変形性関節症、脊椎疾患、重度の四肢外傷の症例が増加
      • 政府機関別啓発プログラムの利用可能性
    • 抑制要因
      • 関節痛用注射剤のコストが高い
    • 機会
      • 変形性関節症の痛みの治療の進歩
      • 関節内注射の利点についての認識の高まり
    • 課題
      • 注射に対する意識が低い
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 関節痛用注射剤市場注射タイプ別

  • コルチコステロイド注射
  • ヒアルロン酸注射

第7章 関節痛用注射剤市場ジョイントタイプ別

  • 脊椎の椎間関節
  • 股関節
  • 膝と足首
  • 肩と肘

第8章 関節痛用注射剤市場：流通チャネル別

  • 病院薬局
  • オンライン薬局
  • 小売薬局

第9章 南北アメリカの関節痛用注射剤市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の関節痛用注射剤市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの関節痛用注射剤市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. JOINT PAIN INJECTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. JOINT PAIN INJECTIONS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2022 VS 2030 (%)
  • FIGURE 5. JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2022 VS 2030 (%)
  • FIGURE 6. JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 7. JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. JOINT PAIN INJECTIONS MARKET DYNAMICS
  • FIGURE 9. JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. JOINT PAIN INJECTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. JOINT PAIN INJECTIONS MARKET SIZE, BY FACET JOINTS OF THE SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. JOINT PAIN INJECTIONS MARKET SIZE, BY HIP JOINT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE & ANKLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER & ELBOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 13. JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. JOINT PAIN INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. JOINT PAIN INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 144. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 145. JOINT PAIN INJECTIONS MARKET LICENSE & PRICING
目次
Product Code: MRR-43470FC6083E

The Global Joint Pain Injections Market is forecasted to grow significantly, with a projected USD 4,555.40 million in 2023 at a CAGR of 10.92% and expected to reach a staggering USD 9,423.97 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Joint Pain Injections Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Joint Pain Injections Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Injection Type, market is studied across Corticosteroid Injections and Hyaluronic Acid Injections. The Hyaluronic Acid Injections is projected to witness significant market share during forecast period.

Based on Joint Type, market is studied across Facet Joints of the Spine, Hip Joint, Knee & Ankle, and Shoulder & Elbow. The Knee & Ankle is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Retail Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Joint Pain Injections Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Joint Pain Injections Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Joint Pain Injections Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Joint Pain Injections Market?

4. What is the competitive strategic window for opportunities in the Global Joint Pain Injections Market?

5. What are the technology trends and regulatory frameworks in the Global Joint Pain Injections Market?

6. What is the market share of the leading vendors in the Global Joint Pain Injections Market?

7. What modes and strategic moves are considered suitable for entering the Global Joint Pain Injections Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Joint Pain Injections Market, by Injection Type, 2022 vs 2030
  • 4.3. Joint Pain Injections Market, by Joint Type, 2022 vs 2030
  • 4.4. Joint Pain Injections Market, by Distribution Channel, 2022 vs 2030
  • 4.5. Joint Pain Injections Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of joint disorders across globe
      • 5.1.1.2. Rising cases of rheumatoid arthritis, osteoarthritis, spinal disorders, and severe limb trauma
      • 5.1.1.3. Availability of awareness programs by government organizations
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the joint pain injections
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in osteoarthritis pain treatment
      • 5.1.3.2. Growing awareness about benefits of intra-articular injections
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness regarding injections
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Joint Pain Injections Market, by Injection Type

  • 6.1. Introduction
  • 6.2. Corticosteroid Injections
  • 6.3. Hyaluronic Acid Injections

7. Joint Pain Injections Market, by Joint Type

  • 7.1. Introduction
  • 7.2. Facet Joints of the Spine
  • 7.3. Hip Joint
  • 7.4. Knee & Ankle
  • 7.5. Shoulder & Elbow

8. Joint Pain Injections Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Joint Pain Injections Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Joint Pain Injections Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Joint Pain Injections Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing